๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Surgical treatment of metastatic brain tumors

โœ Scribed by Frederick F. Lang; Raymond Sawaya


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
285 KB
Volume
14
Category
Article
ISSN
8756-0437

No coin nor oath required. For personal study only.

โœฆ Synopsis


Key elements in the modern surgical treatment of metastatic brain tumors are a firm grasp of criteria for selection of proper surgical candidates and a thorough grounding in the surgical approaches to, and the anatomy of, cerebral metastases. It is important to realize that the presence of multiple or recurrent brain metastases does not automatically contraindicate surgery because in properly selected patients, resection of multiple metastases or reoperation for recurrent metastases can extend survival and enhance the quality of life. Appropriate treatment of metastatic brain tumors frequently requires the judicious use of modalities such as open craniotomy, whole brain radiotherapy, and stereotactic radiosurgery. In order to assure the best outcome of patients with cerebral metastases, it is necessary to have an awareness of how these modalities can best complement one another and to apply them accordingly. Semin.


๐Ÿ“œ SIMILAR VOLUMES


Whole brain radiotherapy in the treatmen
โœ Sandra S. Vermeulen ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 43 KB ๐Ÿ‘ 2 views

Previous prospective and retrospective trials have failed to demonstrate the best treatment approach for patients with brain metastases. As a result, fractionated whole brain radiotherapy (WBRT) has been the mainstay of treatment for several decades. However, with improved surgical techniques and th

Treatment of Metastatic Chemodectoma
โœ Vickie Massey; Kent Wallner ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 260 KB
Chemotherapy of brain tumors
โœ Michael D. Prados; Carolyn Russo ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 52 KB

For many years, chemotherapy has been utilized for the treatment of malignant brain tumors with minimal success. This particularly true with chemotherapy in adult malignant gliomas for which no new drug has been approved for use since the initial studies using nitrosoureas and procarbazine in the ea